NO20090251L - Camptotecinderivater med antitumoraktivitet - Google Patents
Camptotecinderivater med antitumoraktivitetInfo
- Publication number
- NO20090251L NO20090251L NO20090251A NO20090251A NO20090251L NO 20090251 L NO20090251 L NO 20090251L NO 20090251 A NO20090251 A NO 20090251A NO 20090251 A NO20090251 A NO 20090251A NO 20090251 L NO20090251 L NO 20090251L
- Authority
- NO
- Norway
- Prior art keywords
- tumor activity
- derivatives
- camptotecin
- camptotecin derivatives
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Abstract
Nye camptotecinderivater som har antitumoraktivitet, prosessen for fremstilling derav, anvendelsen derav som antitumorlegemiddel og farmasøytiske sammensetninger inneholdende dem.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001473A ITMI20061473A1 (it) | 2006-07-26 | 2006-07-26 | Derivati della camptotecina ad attivita antitumorale |
PCT/EP2007/006243 WO2008011994A1 (en) | 2006-07-26 | 2007-07-13 | Camptothecin derivatives with antitumor activity |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20090251L true NO20090251L (no) | 2009-01-16 |
NO341812B1 NO341812B1 (no) | 2018-01-29 |
Family
ID=38668829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090251A NO341812B1 (no) | 2006-07-26 | 2009-01-16 | Camptotecinderivater med antitumoraktivitet |
Country Status (21)
Country | Link |
---|---|
US (1) | US8217053B2 (no) |
EP (1) | EP2044079B1 (no) |
JP (1) | JP5313894B2 (no) |
KR (1) | KR101412157B1 (no) |
CN (1) | CN101495486B (no) |
AU (1) | AU2007278500B2 (no) |
BR (1) | BRPI0714553B8 (no) |
CA (1) | CA2658900C (no) |
DK (1) | DK2044079T3 (no) |
ES (1) | ES2561356T3 (no) |
HK (1) | HK1135691A1 (no) |
HU (1) | HUE027890T2 (no) |
IL (1) | IL196653A (no) |
IT (1) | ITMI20061473A1 (no) |
MX (1) | MX2009000827A (no) |
NO (1) | NO341812B1 (no) |
PL (1) | PL2044079T3 (no) |
PT (1) | PT2044079E (no) |
RU (1) | RU2450008C2 (no) |
SI (1) | SI2044079T1 (no) |
WO (1) | WO2008011994A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2907824T1 (en) * | 2012-10-11 | 2018-06-29 | Daiichi Sankyo Company, Limited | THE HEALTHY KJUBIER OF THE PROTITEL |
US9872924B2 (en) | 2012-10-19 | 2018-01-23 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
KR101586030B1 (ko) * | 2014-01-22 | 2016-01-15 | 주식회사 엘지생활건강 | 캄프토테신을 유효성분으로 포함하는 체모 성장 억제용 조성물 |
KR102190548B1 (ko) | 2014-01-31 | 2020-12-14 | 다이이찌 산쿄 가부시키가이샤 | 항-her2 항체-약물 접합체 |
BR112017027690A2 (pt) | 2015-06-29 | 2018-10-09 | Daiichi Sankyo Co Ltd | método para produção de uma composição de conjugado anticorpo-fármaco, e, composição de conjugado anticorpo-fármaco |
EP3552626A4 (en) | 2016-12-12 | 2020-06-10 | Daiichi Sankyo Company, Limited | ASSOCIATION OF AN ANTIBODY DRUG CONJUGATE AND AN IMMUNE CONTROL POINT INHIBITOR |
CN110382535A (zh) | 2017-01-17 | 2019-10-25 | 第一三共株式会社 | 抗-gpr20抗体以及抗-gpr20抗体-药物缀合物 |
TWI794230B (zh) | 2017-05-15 | 2023-03-01 | 日商第一三共股份有限公司 | 抗cdh6抗體及抗cdh6抗體-藥物結合物、以及其製造方法 |
CN111065621B (zh) | 2017-08-31 | 2024-01-26 | 第一三共株式会社 | 制备抗体-药物缀合物的新方法 |
SG11202000997YA (en) | 2017-08-31 | 2020-03-30 | Daiichi Sankyo Co Ltd | Improved method for producing antibody-drug conjugate |
EP4249002A3 (en) | 2018-05-18 | 2023-11-22 | Daiichi Sankyo Co., Ltd. | Anti-muc1- exatecan antibody-drug conjugate |
US10568873B1 (en) * | 2019-02-14 | 2020-02-25 | United Arab Emirates University | Safranal-sorafenib combination therapy for liver cancer |
CN112905237A (zh) | 2019-12-04 | 2021-06-04 | 北京百度网讯科技有限公司 | 指令预取方法、装置、设备和介质 |
CN112225745B (zh) * | 2020-11-16 | 2021-10-12 | 烟台大学 | 一种具有抗肿瘤活性的异片螺素类化合物、制备方法及用途 |
CN117510515A (zh) * | 2022-07-28 | 2024-02-06 | 明慧医药(杭州)有限公司 | 适用于抗体-药物偶联物的毒素分子 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4391909A (en) * | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
US5972955A (en) * | 1995-06-06 | 1999-10-26 | Dr. Reddy's Research Foundation | Water soluble C-ring analogues of 20(S)-camptothecin |
FR2757515B1 (fr) * | 1996-12-20 | 2000-05-05 | Sod Conseils Rech Applic | Formes prodrogues et nouveaux analogues de la camptothecine, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant |
US6881555B2 (en) * | 1999-03-19 | 2005-04-19 | Aventis Pharmaceuticals Inc. | AKT nucleic acids, polypeptides, and uses thereof |
WO2003027118A1 (en) * | 2001-09-25 | 2003-04-03 | Dr.Reddy's Laboratories Ltd. | Pharmaceutically acceptable salts of 20(s)-camptothecins |
US20060084167A1 (en) * | 2004-10-16 | 2006-04-20 | Cohenford Menashi A | Formation of Hybrid Cells by Fusion of Lineage Committed Cells with Stem Cells |
-
2006
- 2006-07-26 IT IT001473A patent/ITMI20061473A1/it unknown
-
2007
- 2007-07-13 CN CN2007800283564A patent/CN101495486B/zh active Active
- 2007-07-13 EP EP07786063.3A patent/EP2044079B1/en active Active
- 2007-07-13 BR BRPI0714553A patent/BRPI0714553B8/pt not_active IP Right Cessation
- 2007-07-13 RU RU2009102243/04A patent/RU2450008C2/ru active
- 2007-07-13 PT PT77860633T patent/PT2044079E/pt unknown
- 2007-07-13 KR KR1020097001595A patent/KR101412157B1/ko active IP Right Grant
- 2007-07-13 HU HUE07786063A patent/HUE027890T2/en unknown
- 2007-07-13 SI SI200731737T patent/SI2044079T1/sl unknown
- 2007-07-13 CA CA2658900A patent/CA2658900C/en not_active Expired - Fee Related
- 2007-07-13 PL PL07786063T patent/PL2044079T3/pl unknown
- 2007-07-13 DK DK07786063.3T patent/DK2044079T3/en active
- 2007-07-13 MX MX2009000827A patent/MX2009000827A/es active IP Right Grant
- 2007-07-13 ES ES07786063.3T patent/ES2561356T3/es active Active
- 2007-07-13 JP JP2009521137A patent/JP5313894B2/ja not_active Expired - Fee Related
- 2007-07-13 AU AU2007278500A patent/AU2007278500B2/en not_active Ceased
- 2007-07-13 US US12/374,963 patent/US8217053B2/en active Active
- 2007-07-13 WO PCT/EP2007/006243 patent/WO2008011994A1/en active Application Filing
-
2009
- 2009-01-16 NO NO20090251A patent/NO341812B1/no not_active IP Right Cessation
- 2009-01-22 IL IL196653A patent/IL196653A/en active IP Right Grant
-
2010
- 2010-01-15 HK HK10100446.8A patent/HK1135691A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK2044079T3 (en) | 2016-02-29 |
CN101495486B (zh) | 2013-05-15 |
ES2561356T3 (es) | 2016-02-25 |
BRPI0714553A2 (pt) | 2013-03-26 |
KR20090033456A (ko) | 2009-04-03 |
NO341812B1 (no) | 2018-01-29 |
RU2450008C2 (ru) | 2012-05-10 |
RU2009102243A (ru) | 2010-07-27 |
IL196653A0 (en) | 2009-11-18 |
ITMI20061473A1 (it) | 2008-01-27 |
PL2044079T3 (pl) | 2016-06-30 |
BRPI0714553B8 (pt) | 2021-05-25 |
HUE027890T2 (en) | 2016-11-28 |
CN101495486A (zh) | 2009-07-29 |
SI2044079T1 (sl) | 2016-02-29 |
JP2009544634A (ja) | 2009-12-17 |
EP2044079B1 (en) | 2015-12-09 |
US20100120816A1 (en) | 2010-05-13 |
WO2008011994A1 (en) | 2008-01-31 |
JP5313894B2 (ja) | 2013-10-09 |
CA2658900A1 (en) | 2008-01-31 |
MX2009000827A (es) | 2009-02-03 |
BRPI0714553B1 (pt) | 2020-11-17 |
CA2658900C (en) | 2015-09-15 |
IL196653A (en) | 2015-04-30 |
HK1135691A1 (en) | 2010-06-11 |
KR101412157B1 (ko) | 2014-06-25 |
US8217053B2 (en) | 2012-07-10 |
AU2007278500A2 (en) | 2010-09-09 |
EP2044079A1 (en) | 2009-04-08 |
AU2007278500A1 (en) | 2008-01-31 |
PT2044079E (pt) | 2016-03-09 |
AU2007278500B2 (en) | 2012-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090251L (no) | Camptotecinderivater med antitumoraktivitet | |
AU2018260815A1 (en) | Treatment of Acute Lymphoblastic Leukemia | |
TNSN08326A1 (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
WO2012142511A3 (en) | Orthomolecular compositions and their use in stabilizing the extracellular matrix | |
DOP2010000013A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
TW200611904A (en) | Aza-bicyclononanes | |
ECSP088666A (es) | Derivados de las benzamidas y heteroarenos | |
CY1119798T1 (el) | Μορφη iv υδροχλωρικης ιβαμπραδινης | |
NO20090295L (no) | Substituerte heteroarylderivater | |
UA107474C2 (uk) | Похідні хроменону з антипухлинною активністю | |
MX2009011533A (es) | Productos quimicos, composiciones y metodos para tratamiento y prevencion de infecciones de virus orthopox y enfermedades asociadas. | |
NO20071504L (no) | Pyrimidinderivanter. | |
UY30349A1 (es) | Ligandos del receptor de acetilcolina de tipo nicotinico | |
UY30835A1 (es) | 8-alquinilxantinas y derivados | |
CR20110210A (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales | |
MX2010002733A (es) | Terapia de intervalo para el tratamiento de tinnitus. | |
MY149854A (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
NO20084352L (no) | Dimerer av artemisininderivater, fremstilling derav og terapeutisk anvendelse derav | |
IN2012DN02793A (no) | ||
NO20090252L (no) | Camptotecinderivater med antitumoraktivitet | |
GB0615105D0 (en) | Novel compounds | |
NO20091386L (no) | Fenyloksyanilinderivater | |
CY1110787T1 (el) | Νεα μορφινικα παραγωγα | |
EA201400444A1 (ru) | Производные 2-оксопиперидинила |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |